A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/53 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 9/50 (2006.01) A61K 47/12 (2006.01) A61K 47/32 (2006.01) A61K 47/34 (2006.01) A61K 47/38 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2598948
A once-a-day, extended-release formulation of lamotrigine, exhibiting a significantly similar release rate throughout the GI tract irrespective of the pH of the environment, is provided. The formulation comprises lamotrigine, an organic acid, a release enhancing polymer and a release controlling polymer. The use of the formulation for the treatment of the neurological disorders is also disclosed.
L'invention porte sur une formulation de lamotrigine à libération prolongée, à administrer une fois par jour, présentant une vitesse de libération significativement analogue dans tout le tractus gastro-intestinal indépendamment du pH de l'environnement. La formulation comprend de la lamotrigine, un acide organique, un polymère améliorant la libération et un polymère contrôlant la libération. L'invention porte également sur l'utilisation de la formulation pour le traitement des troubles neurologiques.
Bhatt Padmanabh P.
Edwards Kevin
Kidane Argaw
Smart & Biggar
Supernus Pharmaceuticals Inc.
LandOfFree
Enhanced formulations of lamotrigine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced formulations of lamotrigine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced formulations of lamotrigine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1425474